ETRACS 2x Leveraged MSCI US Quality Factor TR ETN
QULL
1 hedge funds and large institutions have $4.25K invested in ETRACS 2x Leveraged MSCI US Quality Factor TR ETN in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% less ownership
Funds ownership: 0.04% → 0.03% (-0%)
19% less capital invested
Capital invested by funds: $5.25K → $4.25K (-$1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$580 |
QULL Hedge Fund Activity: Q1 2025 in Review
1 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) for Q1 2025, worth a combined $4.25K — down 19% from $5.25K a quarter earlier.
Fund positioning in QULL was balanced in Q1 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $580.
- 1 institutional investor held ETRACS 2x Leveraged MSCI US Quality Factor TR ETN (QULL) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $4.25K of ETRACS 2x Leveraged MSCI US Quality Factor TR ETN stock for Q1 2025, down 19% quarter-over-quarter.
- 0 funds opened new ETRACS 2x Leveraged MSCI US Quality Factor TR ETN positions in Q1 2025 and 0 closed out.
- The largest ETRACS 2x Leveraged MSCI US Quality Factor TR ETN seller in Q1 2025 was UBS Group, an estimated $580 sold.
Based on aggregated 13F filings for Q1 2025.